Orchid Pharma's Alathur API facility successfully completes US FDA inspection: Our Bureau, Mumbai Thursday, February 20, 2025, 11:30 Hrs [IST] Orchid Pharma Ltd., a vertically int ...

JEIL PHARMACEUTICAL secures South Korea rights for Shionogis antibiotic Petrozajoo JEIL PHARMACEUTICAL prepares to enhance ...

The US FDA conducted an inspection at Orchid Pharma's Active Pharmaceutical Ingredient (API) manufacturing facility in ...

Orchid Pharma Ltd., a vertically integrated pharmaceutical company, has received seven minor observations from the U.S. Food ...

Although group A streptococcus has not developed resistance, antibiotic therapy fails to eradicate the infection in some patients. Many authors have suggested using a cephalosporin as an ...

The company is dedicated to maintaining the highest quality and regulatory standards while supporting smooth global business ...

These will slot into Shionogi’s portfolio alongside Fetroja (cefiderocol), billed as the first and only siderophore cephalosporin antibiotic that has a novel mechanism for penetrating the outer ...

"The inspection, which commenced on 10 February 2025 and concluded on 18 February 2025, resulted in seven minor observations, ...

Antibiotics like penicillin and cephalosporins are crucial for treating infections, while research tackles antibiotic ...

The inspection, which commenced on 10 February 2025 and concluded on 18 February 2025, resulted in seven minor observations, ...